European guidelines on managing adverse effects of medication for ADHD
- نوع فایل : کتاب
- زبان : انگلیسی
- مؤلف : J. Graham T. Banaschewski J. Buitelaar D. Coghill M. Danckaerts R. W. Dittmann M. Do¨pfner R. Hamilton C. Hollis M. Holtmann M. Hu
- چاپ و سال / کشور: 2010
Description
The safety of ADHD medications is not fully known. Concerns have arisen about both a lack of contemporary- standard information about medications first licensed several decades ago, and signals of possible harm arising from more recently developed medications. These relate to both relatively minor adverse effects and extremely serious issues such as sudden cardiac death and suicidality. A guidelines group of the European Network for Hyperkinetic Disorders (EUNETHYDIS) has therefore reviewed the literature, recruited renowned clinical subspecialists and consulted as a group to examine these concerns. Some of the effects examined appeared to be minimal in impact or difficult to distinguish from risk to untreated populations. However, several areas require further study to allow a more precise understanding of these risks.
Eur Child Adolesc Psychiatry (2011) 20:17–37 DOI 10.1007/s00787-010-0140-6 Received: 24 March 2010 / Accepted: 6 October 2010 / Published online: 3 November 2010
